IRADIMED CORP

IRMD · XNAS

CIK 1325618fmd_1XDNFHWY5FSQHKFBN1ATWX6DWEManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 54 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	32	23	30	39	32	42	53	66	73	84
Cost of revenue	6	6	7	9	8	10	12	15	17	19
Gross profit	26	18	23	30	24	32	41	50	56	64
Realized investment gains (losses)	(0)	(0)	(0)	0	0	0	0	–	–	–
Research and development	1	2	2	1	2	2	2	3	3	3
Selling, general and administrative	14	15	16	20	22	20	23	27	32	35
Total operating expenses	15	16	17	21	24	22	26	30	34	38
Operating income	11	1	6	9	(1)	10	16	20	22	26
Interest and investment income	0	0	0	0	0	0	1	2	2	2
Other non-operating income (expense)	0	0	0	0	0	0	1	2	2	2
Income before taxes	11	1	6	9	(1)	10	16	22	24	28
Income tax expense	4	1	(0)	(1)	(2)	1	3	5	5	6
Net income from continuing operations	7	0	6	10	1	9	13	17	19	22
Net income	7	0	6	10	1	9	13	17	19	22